When Will Full Adherence To EU (536/2014) Be Required?

In January 2022, EU (536/2014) – a binding regulation across all members of the EU – came into effect. The new regulation will streamline procedures and remove duplication of single submission via a single EU portal. It also focuses on an assessment procedure leading to a single decision, rules on the protection of subjects and informed consent, a greater level of harmonization, and transparency requirements.

For this Clinical Leader Live I spoke to Sylvia Marecki, Marieke Meulemans, Adam Lambert, and Thomas Hagemeijer about the opportunities and challenges of EU (536/2014). In this segment, Marieke Meulemans discusses when full adherence to the regulation will be required and what drug developers can expect in terms of timelines.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader